HOW WHO IS PREPARING FOR THE NEXT "PANDEMIC/S"
While Freedom of Information Responses reveal that health/science institutions around the world (217 and counting!) have no record of SARS-COV-2 isolation/purification, anywhere, ever:
https://christinemasseyfois.substack.com/p/1-page-notarized-declaration-re-hundreds
WHO is pushing for more vaccines and Remdesivir in the ongoing fight against viruses.
The WHO R&D Blueprint organized a consultation with the MARVAC partners and focal points from at-risk countries to discuss Marburg vaccine and therapeutic candidates and integrating research during an outbreak.
Session 1. Review of evidence and prioritization of candidate vaccines
Candidate vaccines developers’ update:
ChAd3-MARV Program Update (Sabin Vaccine Institute)
http://web.archive.org/web/20131230213446/http://www.sabin.org/our-experts
http://web.archive.org/web/20140513022833/http://www.sabin.org/sars-vaccine
Live, Attenuated Recombinant Vesicular Stomatitis (rVSV) Vectored Vaccine (Public Health Vaccines)
https://phvaccines.com/leadership.html
Joan Fusco, PhD
Chief Operating Officer
Dr. Fusco earned her Ph.D. in Microbiology (Biological Sciences; bacterial virulence/immunity factors) from the University of Pittsburgh. She has deep experience in the development of a multitude of vaccine products for existing and emerging infectious diseases and biothreats, including filoviruses, meningitis A/B/C, Hib, Group B strep, Group A strep, pseudomonas, gonorrhea, diphtheria, tetanus, pertussis, polio, pneumococcus, West Nile, Japanese encephalitis, smallpox, anthrax, plague, influenza (seasonal and pandemic), and Zika. She has presented at numerous conferences and served on Welcome Trust’s Ebola Vaccine Team B.
https://onehealthinitiative.com/ Home - One Health Initiative
Crozet BioPharma is a biotechnology company developing medical countermeasures for infectious disease and cancer.
https://www.biospace.com/article/releases/crozet-biopharma-announces-10-8-million-agreement-to-support-development-of-single-dose-nipah-virus-vaccine-through-partnership-with-public-health-vaccines/ Published: Aug 26, 2019
Crozet BioPharma, LLC (Crozet) announced today a $10.8 million total value partnering agreement with Public Health Vaccines, LLC (PHV) to advance the development and manufacture of a vaccine against the Nipah virus, listed as a priority pathogen by the World Health Organization.1
Michael McGinnis
Chief Business Officer
Michael McGinnis has nearly twenty-five years of general management, international business development, strategic planning, alliance management, marketing, and program management experience in the Pharmaceutical and Biotechnology industries.
Joe Crowell
Vice President, CMC
Most recently having been a leader of and founding partner at Crozet BioPharma, Joe continues to build on a history with companies such as BioProtection Systems/NewLink Genetics, GSK/Novartis Vaccines, GE/Xcellerex, Wyeth, Lonza, Becton Dickinson, Repligen Corp. and Abbott Biotech.
etc.
They state that there are no serious adverse effects from their Marburg and C-19 vaccines:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313058/pdf/main.pdf
A total of 1020 non-serious adverse events were reported within 48 h of the first dose of vaccination. Common adverse events included feeling unwell (N-186, 19%), headache (N-171, 17.4%), fever (N-123, 12.5%), fatigue (N-121, 12.3%) and muscle ache (N- 110,11.2%). 123 non-serious AEFI were reported between 3 and 7 days (day 8). 66 non - serious adverse events were reported between 8 and 14 days (day15). No adverse events were reported in the last two weeks. Two serious adverse events (altered sensorium) were noted in the first 48 h of vaccination which can be considered negligible.
We studied adverse events for four weeks from each dose.
However, here are a few articles on serious side effects after administration of this product:
https://www.nejm.org/doi/full/10.1056/NEJMoa2104882 Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
Within 10 days after receiving a first immunization with ChAdOx1 nCoV-19, five health care workers 32 to 54 years of age presented with thrombosis in unusual sites and severe thrombocytopenia.
https://pubmed.ncbi.nlm.nih.gov/37202971/ Acute abducens nerve palsy with acute disseminated encephalomyelitis-like presentation following COVID-19 vaccination - PubMed (nih.gov)
We report two adult cases of abducens nerve palsy presenting immediately (within weeks) after they received the first dose of Covishield vaccination.
https://www.nature.com/articles/s41467-021-25010-x Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia | Nature Communications
Here we report two cases of malignant middle cerebral artery (MCA) infarct and thrombocytopenia 9-10 days following ChAdOx1 nCoV-19 vaccination.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444739/ Large hemorrhagic stroke after ChAdOx1 nCoV‐19 vaccination: A case report - PMC (nih.gov)
To report a case of a large hemorrhagic stroke 5 days after ChAdOx1 nCoV‐19 vaccination.
https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-022-07186-9 Herpes simplex encephalitis following ChAdOx1 nCoV-19 vaccination: a case report and review of the literature | BMC Infectious Diseases | Full Text
In this article intends to report a case of herpes simplex encephalitis in a 27-year-old male patient who was vaccinated with the ChAdOx1 nCoV-19 vaccine.
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8480454/ COVID-19 Vaccine-Induced Thrombosis and Thrombocytopenia: First Confirmed Case from India
An 18-year-old boy was brought to the emergency with complaints of headache and recurrent vomiting for five days. He died 7 days after hospitalization.
https://surgicalneurologyint.com/surgicalint-articles/a-rare-case-of-vaccine-induced-immune-thrombosis-and-thrombocytopenia-and-approach-to-management/
A 32-year-old woman.
https://content.iospress.com/articles/international-journal-of-risk-and-safety-in-medicine/jrs210048 An old entity, a new trigger: Post COVID-19 vaccine pityriasis rubra pilaris
ETC. ETC. ETC…
Just "Covid-19" in the VAERS database is reported as an adverse reaction to this so-called vaccine:
https://medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=SYM&EVENTS=ON&VAX=COVID19 Search Results from the VAERS Database (medalerts.org)
COVID-19 - 204,821 - 13.32%
If they really cared about Covid, shouldn't they look at the data?
No, because it's not about Covid, Marburg, Nipah or anything else.
It's about selling this nanotech poison and injecting it!
As soon as I saw Remdesivir (Run, Death is NEAR) in at top of your article, I also thought, "Are you kidding me?"
So glad we practiced 'Just say no'. Hoping that shedding (if a real thing) will not visit us, at least not severely.
Most people will trust they doctor even at this late of a date. (IDIOTS)
But, we are waking up, this information is getting out.
Substack may already be targeted, but let us use it to the max while we can.